Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Iridium Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103420908A reveals a high-yield asymmetric hydrogenation route for Montelukast intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN111574487B details a novel asymmetric hydrogenation method for producing high-purity chiral dihydroisoflavones, offering significant supply chain and cost advantages.
Novel iridium-catalyzed method offers high enantioselectivity. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN116375653A details a high enantioselective iridium-catalyzed method for chiral tetrahydroquinazoline derivatives, offering cost-effective API intermediate manufacturing solutions.